West Virginia 2022 Regular Session

West Virginia House Bill HB4782

Introduced
2/15/22  

Caption

Increase number of pain management visits the insurance companies must cover under the opioid reduction act

Impact

If enacted, HB 4782 would significantly change the landscape of pain management within West Virginia by ensuring that health insurance policies provide better coverage for alternative therapies. This would help reduce the overall dependence on opioids by promoting non-pharmacological treatments. The bill's provisions also emphasize the importance of clinical judgment in determining when patients should be referred for these alternative therapies before resorting to opioids, thus potentially lowering the risk of addiction and improving patient outcomes.

Summary

House Bill 4782 seeks to amend the existing West Virginia Opioid Reduction Act by increasing the number of pain management visits that insurance companies must cover. The bill outlines specific treatment modalities such as physical therapy, occupational therapy, acupuncture, and chiropractic services that healthcare practitioners can prescribe as alternatives to opioid prescriptions. By mandating that insurance providers cover a minimum of 40 visits per event of these therapies, the bill aims to give patients more options for pain management without immediate reliance on potentially addictive opioid medications.

Sentiment

The sentiment surrounding HB 4782 appears to be largely supportive among healthcare advocates and professionals who see it as a progressive step towards addressing the opioid crisis. Many express that increasing access to non-opioid treatment options can lead to better management of chronic pain and ultimately contribute to the reduction of opioid prescriptions. However, there may be concerns about how this will impact insurance companies and their reimbursement processes, which could draw opposition from certain business interests in the insurance sector.

Contention

Notable points of contention may arise regarding the specific number of visits mandated for coverage and the extent to which insurance providers will be obligated to comply. Some stakeholders may argue that 40 visits may be insufficient or excessive, depending on individual treatment needs. Additionally, there may be debates on whether the bill adequately addresses all patients’ needs or if it prioritizes specific therapies over others. Furthermore, how insurance companies implement these changes could lead to disparities in treatment access across different regions of West Virginia.

Companion Bills

No companion bills found.

Previously Filed As

WV S0161

Non-Opioid Pain Management

WV SB248

Increasing availability of prescription non-opioid medications

WV HB241

(New Title) relative to health insurance coverage of pain management services for the management of chronic pain.

WV HB516

A BILL to amend the Code of Virginia by adding a section numbered 38.2-3407.9:06, relating to health insurance; coverage for non-opioid prescription drugs.

WV SB006

Parity for Non-Opioid Pain Management Drugs

WV S03185

Provides outpatient insurance coverage for non-pharmacological treatments and non-opioid drugs for chronic pain.

WV HB1765

Health insurance; coverage for non-opioid prescription drugs.

WV H4165

Non-opiod Pain Management

WV A01921

Provides outpatient insurance coverage for non-pharmacological treatments and non-opioid drugs for chronic pain.

WV HB516

Health insurance; coverage for non-opioid prescription drugs.

Similar Bills

DE SB101

An Act To Amend Title 16 Of The Delaware Code Relating To The Definition Of The Patient-practitioner Relationship.

OR HB3799

Relating to medical treatments with investigational products.

NJ A289

Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.

NJ A4190

Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

IN SB0180

Various health care matters.

MS HB956

Opioid drugs; prescriber shall discuss with patient before prescribing, the risks of the drugs and available alternatives.

OK SB1642

Controlled dangerous substances; authorizing divided quantities for certain acute pain opioid prescriptions. Effective date.

DE SB274

An Act To Amend Title 16 And Title 21 Of The Delaware Code Relating To Delaware Medical Orders For Scope Of Treatment.